10 Cheap US Stocks to Buy According to Analysts

6. The Chemours Company (NYSE:CC)

Forward P/E Ratio as of November 18: 5.52

Number of Hedge Fund Holders: 48

Average Upside Potential as of November 18: 69.26%

The Chemours Company (NYSE:CC) is one of the cheap US stocks to buy according to analysts. On November 10, RBC Capital analyst Arun Viswanathan lowered the firm’s price target on Chemours to $17 from $19 and kept an Outperform rating on the shares after the company saw Q3 2025 earnings miss. Viswanathan noted that the persistent pricing pressure within the TiO2 segment is a major drag for the company. Furthermore, operational setbacks in the Advanced Performance Materials division are currently offsetting the strong financial gains achieved by the Thermal & Specialized Solutions segment.

While these factors have contributed to an overall decline in Chemours’ stock value, the company’s Q3 2025 earnings report showed a strong quarter with performance that exceeded Adjusted EBITDA expectations, largely driven by the Thermal & Specialized Solutions segment. The company’s flagship Opteon refrigerants achieved a Q3 sales record, posting an impressive 80% year-over-year increase in sales.

The company recorded $1.50 billion in net sales for Q3.  However, this was a modest 0.40% decline year-over-year. For Q4 and the full year 2025 as well, Chemours anticipates a decrease in net sales and consolidated adjusted EBITDA due to seasonality and market conditions. Consolidated adjusted EBITDA is expected to range between $130 and $160 million for the fourth quarter. Full year 2025 sales are anticipated to range between $5.7 and $5.8 billion.

The Chemours Company (NYSE:CC) provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.